Antenatal corticosteroids for threatened labour facilitate thyroid maturation among preterm neonates

Area of Science:

• Neonatal endocrinology
• Perinatology
• Pediatric endocrinology

Background:

• Antenatal corticosteroids (ANS) are known to reduce mortality and morbidities in preterm neonates by promoting organ maturation.
• The specific impact of ANS on thyroid function maturation in preterm infants remains a subject of debate.
• Understanding this effect is crucial for optimizing neonatal care and outcomes.

Purpose of the Study:

• To investigate the influence of antenatal corticosteroids (ANS) on the development of thyroid function in preterm infants.
• To compare thyroid function parameters between preterm neonates with complete and incomplete exposure to ANS.
• To assess the relationship between ANS administration and the incidence of hyperthyrotropinemia.

Main Methods:

• A cohort of 99 very low birthweight neonates (<34 weeks gestational age) was studied.
• Infants were categorized into 'complete' (n=49) and 'incomplete' (n=50) ANS exposure groups based on maternal betamethasone dosage and timing relative to birth.
• Serum-free thyroxine, TSH levels, and TRH stimulation tests were performed around 2 weeks of age.

Main Results:

• The incidence of hyperthyrotropinemia (TSH > 15 mIU/L) was significantly lower in the complete ANS group (6%) compared to the incomplete group (22%).
• Exaggerated responses to TRH tests were more common in the incomplete ANS group (44% vs 17%).
• Multivariate analysis indicated that complete ANS administration was associated with a reduced incidence of hyperthyrotropinemia (aOR=0.39).

Conclusions:

• Antenatal corticosteroid administration appears to promote thyroid maturation in preterm neonates.
• Complete exposure to ANS may protect against the development of hyperthyrotropinemia in this vulnerable population.
• Further research can elucidate the mechanisms and clinical implications of ANS on neonatal thyroid function.